Precise Correction of Duchenne Muscular Dystrophy with Exon 51 Deletion by Adenine Base Editing-Induced Exon Skipping in a Humanized Mouse Model

被引：0
|
作者：
Li, Guoling [1 ]
Lin, Jiajia [2 ]
Jin, Ming [2 ]
Li, Zhifang [3 ]
Xiao, Qingquan [1 ]
Shi, Linyu [1 ]
Wang, Ning [2 ]
Chen, Wanjin [2 ]
Xu, Chunlong [3 ]
Yang, Hui [1 ,4 ]
机构：
[1] HuidaGene Therapeut Co Ltd, Shanghai, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China
[3] Lingang Lab, Shanghai, Peoples R China
[4] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
667
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [41] Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
    Galli, Francesco
    Bragg, Laricia
    Rossi, Maira
    Proietti, Daisy
    Perani, Laura
    Bagicaluppi, Marco
    Tonlorenzi, Rossana
    Sibanda, Tendai
    Caffarini, Miriam
    Talapatra, Avraneel
    Santoleri, Sabrina
    Meregalli, Mirella
    Bano-Otalora, Beatriz
    Bigot, Anne
    Bozzoni, Irene
    Bonini, Chiara
    Mouly, Vincent
    Torrente, Yvan
    Cossu, Giulio
    EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 927 - 944
  • [42] Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial
    McDonald, Craig M.
    Shieh, Perry B.
    Abdel-Hamid, Hoda Z.
    Connolly, Anne M.
    Ciafaloni, Emma
    Wagner, Kathryn R.
    Goemans, Nathalie
    Mercuri, Eugenio
    Khan, Navid
    Koenig, Erica
    Malhotra, Jyoti
    Zhang, Wenfei
    Han, Baoguang
    Mendell, Jerry R.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (06) : 989 - 1001
  • [43] 46 BASE PAIR DELETION IN EXON-19 OF DUCHENNE MUSCULAR-DYSTROPHY (DMD) GENE
    MATSUO, M
    NAKAJIMA, T
    NISHIO, H
    KITOH, Y
    TAKUMI, T
    NAKAMURA, H
    MASUMURA, T
    KOGA, J
    PEDIATRIC RESEARCH, 1990, 27 (04) : A134 - A134
  • [44] Effect of different dosing regimens of exon skipping antisense oligonucleotides on functional outcome in the mdx mouse model of Duchenne muscular dystrophy
    Datson, N.
    Weij, R.
    Bijl, S.
    Janson, A.
    Vermue, R.
    Testerink, J.
    van Deutekom, J.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S291 - S291
  • [45] Antisense-mediated Exon 51 skipping restores local dystrophin expression in muscle of Duchenne muscular dystrophy patients
    van Deutekom, Judith
    Janson, Anneke
    Aartsma-Rus, Annemieke
    Platenburg, Gerard
    Verschuuren, Jan
    van Ommen, Gert-Jan
    HUMAN GENE THERAPY, 2007, 18 (10) : 949 - 949
  • [46] The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development
    Vulin, Adeline
    Wein, Nicolas
    Simmons, Tabatha R.
    Rutherford, Andrea M.
    Findlay, Andrew R.
    Yurkoski, Jacqueline A.
    Kaminoh, Yuuki
    Flanigan, Kevin M.
    NEUROMUSCULAR DISORDERS, 2015, 25 (11) : 827 - 834
  • [47] By-passing the nonsense mutation in the 4CV mouse model of muscular dystrophy by induced exon skipping
    Mitrpant, Chalermchai
    Fletcher, Sue
    Iversen, Patrick L.
    Wilton, Steve D.
    JOURNAL OF GENE MEDICINE, 2009, 11 (01): : 46 - 56
  • [48] CONNECT-EDO51: Trial designs to support the development of PGN-EDO51 for Duchenne Muscular dystrophy amenable to exon 51 skipping
    Larkindale, J.
    Vacca, S.
    Cormier, J.
    Shoskes, J.
    Goyal, J.
    Holland, A.
    Lonkar, P.
    Foy, J.
    Mellion, M.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S103 - S103
  • [49] Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse model
    Nordin, Joel Z.
    Aoki, Yoshitsugu
    JOURNAL OF PATHOLOGY, 2019, 249 (03): : 271 - 273
  • [50] A novel single-base mutation mimicking exon deletion of MLPA in symptomatic Duchenne muscular dystrophy carrier
    Cho, Min-Sub
    Lee, Jong-Mok
    ACTA NEUROLOGICA BELGICA, 2021, 121 (01) : 287 - 289
12345